ADVANCED LUNG CANCER
Clinical trials for ADVANCED LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo enters human testing for Tough-to-Treat lung cancer
Disease control Recruiting nowThis study is testing a new drug called MHB036C, given alongside other cancer therapies, in people with advanced lung cancer. The main goals are to find the safest and most effective dose and to see if the combination can help control the cancer. It is an early-stage trial for ad…
Matched conditions: ADVANCED LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
First human trial launches for experimental cancer 'Breaker' drug
Disease control Recruiting nowThis is the first human study testing a new experimental drug called BBO-10203 in people with advanced solid tumors that have spread or cannot be removed by surgery. The main goal is to find safe doses and see how the body processes the drug, both alone and when combined with oth…
Matched conditions: ADVANCED LUNG CANCER
Phase: PHASE1 • Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
First-of-its-Kind inhaled powder vaccine tested for Tough-to-Treat lung cancers
Disease control Recruiting nowThis is an early-stage study testing the safety of a new type of inhaled vaccine for people with advanced lung cancer or other cancers that have spread to the lungs. The vaccine is a dry powder containing mRNA designed to teach the immune system to attack cancer cells. The study …
Matched conditions: ADVANCED LUNG CANCER
Phase: EARLY_PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
BioNTech launches major trial for advanced lung cancer treatment
Disease control Recruiting nowThis study is testing a new combination of two experimental drugs, BNT324 and BNT327, for people with advanced small cell or non-small cell lung cancer. The main goals are to find the safest and most effective dose of the drug combination and to see if it helps shrink tumors. The…
Matched conditions: ADVANCED LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
Smartphone app aims to ease Chemotherapy's harsh side effects
Symptom relief Recruiting nowThis study is testing whether a smartphone app, combined with remote nurse support, helps people with cancer better manage the side effects of their chemotherapy. Over 400 adults with stomach, lung, breast, or colon cancer will use the app to track symptoms and get guidance. The …
Matched conditions: ADVANCED LUNG CANCER
Phase: NA • Sponsor: Ulsan University Hospital • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC
-
Virtual therapy trial aims to ease the heavy burden of advanced cancer
Symptom relief Recruiting nowThis study is testing a new telehealth counseling program called ENGAGE, designed to help people with advanced cancer better manage their symptoms. It will compare ENGAGE to standard supportive care in 190 patients with Stage IV breast, prostate, lung, or colorectal cancer. The m…
Matched conditions: ADVANCED LUNG CANCER
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Mar 24, 2026 12:01 UTC
-
New app aims to ease the burden for lung cancer survivors
Symptom relief Recruiting nowThis study is testing a mobile app called PROMOTE, designed to help people being treated for lung cancer. The app aims to improve physical function, manage symptoms like shortness of breath and sleep problems, and support healthier habits. Researchers will compare the app's effec…
Matched conditions: ADVANCED LUNG CANCER
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Mar 20, 2026 14:48 UTC